Responses
Other content recommended for you
- Lundbeck broke advertising rules
- New drugs from old
- Prescription of proton pump inhibitors in older adults with complex polytherapy
- Who’s watching the watchdogs?
- News and updates from palliativedrugs.com
- Review: short-term benefit of escitalopram versus citalopram for depression uncertain, but big difference in French health insurance costs
- Dose-response effects of selective serotonin reuptake inhibitor monotherapy for the treatment of depression: systematic review of reviews and meta-narrative synthesis
- Widening the debate about conflict of interest: addressing relationships between journalists and the pharmaceutical industry
- Making the best use of available evidence: the case of new generation antidepressants
- Risk of seizures with antidepressants: what is the evidence?